Mergers & Acquisitions, Financing, Equity Capital Markets
Orchestra BioMed, Inc.
01/23
|
$180.0 Million


Piper Sandler served as capital markets advsior for Orchestra BioMed, Inc. on business combination with Health Sciences Acquisitions Corporation 2; joint lead placement agent on a Series D financing; and financial advisor on the strategic collaboration with Medtronic